Cite
HARVARD Citation
Popat, S. et al. (n.d.). Mobocertinib (TAK-788) in epidermal growth factor receptor gene (EGFR) exon 20 insertion mutation-positive (EGFRex20ins+) metastatic non-small cell lung cancer (mNSCLC): results from the platinum-pretreated patients (PPP) cohort of a phase 1/2 study. Lung cancer. pp. S30-S31. [Online].